TD Cowen Maintains Buy on AVITA Medical, Raises Price Target to $22

Benzinga · 3d ago
TD Cowen analyst Joshua Jennings maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the price target from $20 to $22.